Reduced expression of the glucocorticoid receptor due to promoter hypermethylation was observed in breast cancer samples, and particularly, but not exclusively, in ER-positive tumors, but this is likely enough to influence GC responsiveness in the tumor cells [72]. This evidence concerns the gene NR3C1 and breast cancer.